Patents by Inventor Hidekazu Ozeki

Hidekazu Ozeki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity
    Patent number: 8008292
    Abstract: To provide a compound having an excellent inhibitory effect on vanilloid receptor subtype 1 (VR1) activity which is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, neuralgia, etc. and a pharmaceutical composition containing the compound.
    Type: Grant
    Filed: July 15, 2005
    Date of Patent: August 30, 2011
    Assignee: Japan Tobacco Inc.
    Inventors: Yoshihisa Koga, Shinji Yata, Takashi Watanabe, Takuya Matsuo, Takayuki Yamasaki, Masahiro Sakata, Wataru Kondo, Hidekazu Ozeki, Yoshikazu Hori
  • PYRAZOLE COMPOUNDS AND USE THEREOF
    Publication number: 20090036450
    Abstract: The pyrazole compound of the present invention is represented by the following general formula (I). The pyrazole compound of the present invention or a salt thereof or a solvate thereof potently inhibits liver glycogen phosphorylase, and, therefore, is useful as a therapeutic or prophylactic agent for diabetes. wherein each symbol denotes as described in the specifications.
    Type: Application
    Filed: November 20, 2007
    Publication date: February 5, 2009
    Applicant: JAPAN TOBACCO, INC.
    Inventors: Masaki Takagi, Takeshi Nakamura, Isamu Matsuda, Toshihiro Kiguchi, Naoki Ogawa, Hidekazu Ozeki
  • CONDENSED BENZAMIDE COMPOUNDS AND INHIBITORS OF VANILLOID RECEPTOR SUBTYPE 1 (VR1) ACTIVITY
    Publication number: 20060035882
    Abstract: To provide a compound having an excellent inhibitory effect on vanilloid receptor subtype 1 (VR1) activity which is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, neuralgia, etc. and a pharmaceutical composition containing the compound.
    Type: Application
    Filed: July 15, 2005
    Publication date: February 16, 2006
    Applicant: Japan Tobacco Inc.
    Inventors: Yoshihisa Koga, Shinji Yata, Takashi Watanabe, Takuya Matsuo, Takayuki Yamasaki, Masahiro Sakata, Wataru Kondo, Hidekazu Ozeki, Yoshikazu Hori